MedPath

Non-Cirrhotic Hyperammonemia Versus Hyperlactatemia in Septic Patients and Impact of Treatment

Completed
Conditions
Sepsis
Registration Number
NCT06721845
Lead Sponsor
Menoufia University
Brief Summary

Objectives: This study aims to determine the validity of hyperammonemia in predicting true sepsis compared to hyperlactemia in critically ill septic patients.

Background: Sepsis is associated with amino acid flux towards the liver, which increases the ammonia load. The combination of decreased clearance and increased load is thought to be the major cause of increased ammonia in sepsis.

Methodology: 60 septic patients were classified into 2 equal groups, Group I: Septic patients with positive microbial cultures. Group II: septic patients with negative cultures enrolled to obtain serum ammonia and lactic acid levels on admission and every six hours for three days. The primary outcome was to detect ammonia specificity and sensitivity in predicting sepsis in comparison to lactate. The secondary outcomes were need for mechanical ventilation, mortality, and length of stay (LHS) within the intensive care unit.

Detailed Description

Objectives: The study compares between non-cirrhotic hyperammonemia and hyperlactemia in predicting sepsis in critically ill septic patients.

The septic patients were classified into 2 equal groups, Group I: Septic patients with positive microbial cultures. Group II: septic patients with negative cultures enrolled to obtain serum ammonia and lactic acid levels on admission and every six hours for three days, to detect ammonia specificity and sensitivity in predicting sepsis in comparison to lactate. also, need for mechanical ventilation, mortality, and length of stay (LHS) within the intensive care unit were reported.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • adult patients aged 19-75 years old
  • both sexes with severe sepsis and septic shock
  • within the first 48 hours of ICU admission
Exclusion Criteria
  • Hepatic patients (cirrhotic, hepatitis),
  • Renal failure, Ureterosigmoidostomy,
  • Malignancy or on Chemotherapy,
  • Pregnancy,
  • Parenteral nutrition,
  • Autoimmune diseases or Immunosuppressive illness, and
  • Trauma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum ammonia specificity and sensitivity in predicting sepsis in comparison to lactateup to three days.

Blood samples to obtain Serial ammonia and lactic acid levels

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Menoufia Faculty of Medicine

🇪🇬

Shibin Elkoom, Menoufia, Egypt

© Copyright 2025. All Rights Reserved by MedPath